Envista (NVST) Stock Forecast, Price Target & Predictions
NVST Stock Forecast
Envista stock forecast is as follows: an average price target of $20.29 (represents a 7.07% upside from NVST’s last price of $18.95) and a rating consensus of 'Hold', based on 8 wall street analysts offering a 1-year stock forecast.
NVST Price Target
NVST Analyst Ratings
Hold
Envista Price Target by Analyst
Date | Analyst | Company | Price Target | Price when Published | Price Target/Price when Published | Price Target/Last Closing Price |
---|---|---|---|---|---|---|
Oct 31, 2024 | Michael Cherny | Leerink Partners | $23.00 | $20.97 | 9.68% | 21.37% |
Oct 31, 2024 | Jason Bednar | Piper Sandler | $17.00 | $19.23 | -11.60% | -10.29% |
Oct 31, 2024 | Jeff Johnson | Robert W. Baird | $22.00 | $19.23 | 14.40% | 16.09% |
Oct 08, 2024 | Vik Chopra | Wells Fargo | $20.00 | $18.25 | 9.59% | 5.54% |
Sep 23, 2024 | Elizabeth Anderson | Evercore ISI | $23.00 | $19.00 | 21.05% | 21.37% |
Aug 08, 2024 | Michael Cherny | Bank of America Securities | $19.00 | $15.30 | 24.18% | 0.26% |
Jul 30, 2024 | Jonathan Block | Stifel Nicolaus | $18.00 | $16.42 | 9.62% | -5.01% |
Jul 22, 2024 | Jeff Johnson | Robert W. Baird | $17.00 | $16.57 | 2.60% | -10.29% |
Apr 26, 2024 | Erin Wright | Morgan Stanley | $21.00 | $20.02 | 4.90% | 10.82% |
Apr 09, 2024 | Jason Bednar | Piper Sandler | $23.00 | $20.32 | 13.19% | 21.37% |
Feb 06, 2023 | Piper Sandler | $46.00 | $41.21 | 11.62% | 142.74% | |
Jul 21, 2022 | Goldman Sachs | $45.00 | $40.38 | 11.44% | 137.47% | |
Jun 17, 2022 | Stifel Nicolaus | $50.00 | $35.72 | 39.98% | 163.85% | |
Jun 14, 2022 | Jeff Johnson | Robert W. Baird | $46.00 | $38.47 | 19.57% | 142.74% |
Envista Price Target by Period
1M | 3M | 12M | |
---|---|---|---|
# Anlaysts | - | 4 | 10 |
Avg Price Target | - | $20.50 | $20.30 |
Last Closing Price | $18.95 | $18.95 | $18.95 |
Upside/Downside | -100.00% | 8.18% | 7.12% |
Analyst Ratings Upgrades/Downgrades
Date | Company | Previous Rating | New Rating | Rating Change |
---|---|---|---|---|
Oct 31, 2024 | Leerink Partners | Market Perform | Upgrade | |
Oct 31, 2024 | Piper Sandler | Neutral | Neutral | Hold |
Oct 31, 2024 | Needham | Hold | Hold | Hold |
Oct 30, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Oct 08, 2024 | Wells Fargo | Equal-Weight | Initialise | |
Sep 23, 2024 | Evercore ISI | Outperform | Outperform | Hold |
Apr 26, 2024 | Morgan Stanley | Equal-Weight | Downgrade | |
Apr 09, 2024 | Piper Sandler | Neutral | Neutral | Hold |
Feb 08, 2024 | William Blair | Outperform | Market Perform | Downgrade |
Nov 02, 2023 | William Blair | Outperform | Outperform | Hold |
Nov 02, 2023 | Piper Sandler | Overweight | Neutral | Downgrade |
Aug 29, 2022 | Piper Sandler | Overweight | Upgrade | |
Jul 21, 2022 | Goldman Sachs | Buy | Buy | Hold |
Envista Financial Forecast
Envista Revenue Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | - | - | - | - | - | - | - | - | - | - | - | - | $955.30M | - | $929.60M | $627.20M | $660.80M | $631.10M | $645.80M | $631.40M | $651.80M | $607.30M | $740.10M | $709.20M | $732.30M | $640.50M | $362.00M | $547.20M | $720.50M | $659.30M |
Avg Forecast | $695.65M | $650.50M | $672.09M | $651.79M | $669.56M | $627.91M | $648.48M | $628.20M | $646.21M | $590.34M | $646.88M | $634.85M | $638.84M | $643.85M | $655.81M | $632.51M | $658.40M | $629.78M | $650.59M | $629.13M | $634.86M | $652.55M | $707.78M | $645.19M | $668.49M | $523.21M | $332.24M | $569.07M | $729.36M | $669.45M |
High Forecast | $709.02M | $663.00M | $685.00M | $664.31M | $682.42M | $639.98M | $660.94M | $641.29M | $656.43M | $594.78M | $646.88M | $634.85M | $653.99M | $662.21M | $668.41M | $644.66M | $671.05M | $629.78M | $650.59M | $629.13M | $634.86M | $652.55M | $707.78M | $645.19M | $668.49M | $523.21M | $332.24M | $569.07M | $729.36M | $669.45M |
Low Forecast | $684.21M | $639.80M | $661.03M | $641.07M | $658.54M | $617.58M | $637.81M | $621.87M | $632.66M | $585.89M | $646.88M | $634.85M | $611.09M | $634.43M | $645.02M | $622.10M | $647.57M | $629.78M | $650.59M | $629.13M | $634.86M | $652.55M | $707.78M | $645.19M | $668.49M | $523.21M | $332.24M | $569.07M | $729.36M | $669.45M |
# Analysts | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 7 | 10 | 6 | 4 | 4 | 6 | 9 | 4 | 4 | 7 | 5 | 3 | 3 | 8 | 5 | 4 | 8 | 7 | 4 | 4 | 7 | 5 | 3 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 1.50% | - | 1.42% | 0.99% | 1.00% | 1.00% | 0.99% | 1.00% | 1.03% | 0.93% | 1.05% | 1.10% | 1.10% | 1.22% | 1.09% | 0.96% | 0.99% | 0.98% |
Forecast
Envista EBITDA Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 7 | 10 | 6 | 4 | 4 | 6 | 9 | 4 | 4 | 7 | 5 | 3 | 3 | 8 | 5 | 4 | 8 | 7 | 4 | 4 | 7 | 5 | 3 |
EBITDA | - | - | - | - | - | - | - | - | - | - | - | - | $-202.80M | - | $78.90M | $115.30M | $132.50M | $74.80M | $105.40M | $129.50M | $129.60M | $119.00M | $136.50M | $147.10M | $136.00M | $112.10M | $-67.50M | $14.90M | $148.90M | $111.20M |
Avg Forecast | $96.19M | $89.94M | $92.93M | $90.12M | $92.58M | $86.82M | $89.66M | $86.86M | $89.35M | $81.63M | $89.44M | $151.08M | $88.33M | $89.03M | $90.68M | $137.35M | $128.98M | $91.50M | $94.53M | $124.86M | $92.24M | $94.81M | $102.84M | $140.66M | $97.13M | $76.02M | $48.27M | $22.80M | $105.97M | $100.86M |
High Forecast | $98.04M | $91.67M | $94.71M | $91.85M | $94.36M | $88.49M | $91.39M | $88.67M | $90.76M | $82.24M | $89.44M | $181.30M | $90.43M | $91.56M | $92.42M | $164.82M | $154.78M | $91.50M | $94.53M | $149.84M | $92.24M | $94.81M | $102.84M | $168.79M | $97.13M | $76.02M | $48.27M | $27.36M | $105.97M | $121.03M |
Low Forecast | $94.60M | $88.46M | $91.40M | $88.64M | $91.06M | $85.39M | $88.19M | $85.99M | $87.48M | $81.01M | $89.44M | $120.87M | $84.49M | $87.72M | $89.19M | $109.88M | $103.19M | $91.50M | $94.53M | $99.89M | $92.24M | $94.81M | $102.84M | $112.53M | $97.13M | $76.02M | $48.27M | $18.24M | $105.97M | $80.68M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -2.30% | - | 0.87% | 0.84% | 1.03% | 0.82% | 1.12% | 1.04% | 1.41% | 1.26% | 1.33% | 1.05% | 1.40% | 1.47% | -1.40% | 0.65% | 1.41% | 1.10% |
Forecast
Envista Net Income Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 7 | 10 | 6 | 4 | 4 | 6 | 9 | 4 | 4 | 7 | 5 | 3 | 3 | 8 | 5 | 4 | 8 | 7 | 4 | 4 | 7 | 5 | 3 |
Net Income | - | - | - | - | - | - | - | - | - | - | - | - | $-217.40M | - | $47.10M | $43.80M | $73.50M | $47.60M | $47.10M | $74.90M | $42.50M | $80.20M | $90.10M | $71.70M | $108.40M | $35.60M | $-93.50M | $-17.20M | $56.10M | $62.10M |
Avg Forecast | $62.84M | $56.79M | $58.32M | $54.26M | $57.35M | $47.55M | $46.16M | $43.65M | $39.09M | $15.21M | $46.57M | $84.45M | $58.96M | $78.34M | $70.96M | $76.77M | $85.39M | $81.58M | $78.99M | $69.79M | $73.12M | $69.87M | $78.23M | $68.56M | $71.28M | $17.07M | $-39.30M | $-26.32M | $84.50M | $56.32M |
High Forecast | $64.41M | $58.21M | $59.77M | $55.61M | $58.78M | $48.74M | $47.32M | $54.12M | $45.89M | $15.59M | $46.60M | $101.34M | $64.32M | $83.45M | $72.74M | $92.13M | $102.47M | $81.58M | $78.99M | $83.75M | $73.12M | $69.87M | $78.23M | $82.27M | $71.28M | $17.07M | $-39.30M | $-21.05M | $84.50M | $67.59M |
Low Forecast | $61.50M | $55.58M | $57.07M | $53.10M | $56.12M | $46.54M | $45.18M | $36.66M | $32.30M | $14.88M | $46.54M | $67.56M | $53.60M | $73.23M | $69.45M | $61.42M | $68.31M | $81.58M | $78.99M | $55.83M | $73.12M | $69.87M | $78.23M | $54.85M | $71.28M | $17.07M | $-39.30M | $-31.58M | $84.50M | $45.06M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -3.69% | - | 0.66% | 0.57% | 0.86% | 0.58% | 0.60% | 1.07% | 0.58% | 1.15% | 1.15% | 1.05% | 1.52% | 2.09% | 2.38% | 0.65% | 0.66% | 1.10% |
Forecast
Envista SG&A Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 7 | 10 | 6 | 4 | 4 | 6 | 9 | 4 | 4 | 7 | 5 | 3 | 3 | 8 | 5 | 4 | 8 | 7 | 4 | 4 | 7 | 5 | 3 |
SG&A | - | - | - | - | - | - | - | - | - | - | - | - | $260.20M | - | $272.90M | $266.10M | $253.60M | $264.20M | $279.50M | $258.20M | $272.30M | $250.60M | $283.10M | $258.90M | $264.60M | $248.80M | $241.90M | $271.50M | $276.00M | $252.00M |
Avg Forecast | $288.10M | $269.40M | $278.34M | $269.93M | $277.29M | $260.04M | $268.56M | $260.16M | $267.62M | $244.48M | $267.89M | $291.12M | $264.57M | $266.64M | $271.60M | $264.65M | $271.00M | $260.81M | $269.43M | $240.60M | $262.92M | $270.24M | $293.12M | $247.57M | $276.85M | $216.68M | $137.59M | $415.39M | $302.05M | $228.56M |
High Forecast | $293.63M | $274.57M | $283.68M | $275.11M | $282.61M | $265.04M | $273.72M | $265.58M | $271.85M | $246.32M | $267.89M | $349.34M | $270.84M | $274.25M | $276.81M | $317.59M | $325.20M | $260.81M | $269.43M | $288.71M | $262.92M | $270.24M | $293.12M | $297.08M | $276.85M | $216.68M | $137.59M | $498.47M | $302.05M | $274.27M |
Low Forecast | $283.35M | $264.96M | $273.76M | $265.49M | $272.73M | $255.76M | $264.14M | $257.54M | $262.01M | $242.64M | $267.89M | $232.90M | $253.07M | $262.74M | $267.13M | $211.72M | $216.80M | $260.81M | $269.43M | $192.48M | $262.92M | $270.24M | $293.12M | $198.05M | $276.85M | $216.68M | $137.59M | $332.32M | $302.05M | $182.85M |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | 0.98% | - | 1.00% | 1.01% | 0.94% | 1.01% | 1.04% | 1.07% | 1.04% | 0.93% | 0.97% | 1.05% | 0.96% | 1.15% | 1.76% | 0.65% | 0.91% | 1.10% |
Forecast
Envista EPS Forecast
Quarter
Dec 26 | Sep 26 | Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | Mar 25 | Dec 24 | Sep 24 | Jun 24 | Mar 24 | Dec 23 | Sep 23 | Jun 23 | Mar 23 | Dec 22 | Sep 22 | Jun 22 | Mar 22 | Dec 21 | Sep 21 | Jun 21 | Mar 21 | Dec 20 | Sep 20 | Jun 20 | Mar 20 | Dec 19 | Sep 19 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
# Analysts | 6 | 3 | 3 | 3 | 2 | 2 | 3 | 7 | 10 | 6 | 4 | 4 | 6 | 9 | 4 | 4 | 7 | 5 | 3 | 3 | 8 | 5 | 4 | 8 | 7 | 4 | 4 | 7 | 5 | 3 |
EPS | - | - | - | - | - | - | - | - | - | - | - | - | $-1.27 | - | $0.29 | $0.27 | $0.45 | $0.29 | $0.29 | $0.46 | $0.26 | $0.58 | $0.56 | $0.45 | $0.68 | $0.22 | $-0.59 | $-0.11 | $0.35 | $0.48 |
Avg Forecast | $0.36 | $0.33 | $0.34 | $0.31 | $0.33 | $0.28 | $0.27 | $0.25 | $0.23 | $0.09 | $0.27 | $0.32 | $0.34 | $0.45 | $0.41 | $0.41 | $0.49 | $0.47 | $0.46 | $0.44 | $0.42 | $0.41 | $0.45 | $0.32 | $0.41 | $0.10 | $-0.23 | $0.10 | $0.49 | $0.43 |
High Forecast | $0.37 | $0.34 | $0.35 | $0.32 | $0.34 | $0.28 | $0.27 | $0.31 | $0.27 | $0.09 | $0.27 | $0.32 | $0.37 | $0.48 | $0.42 | $0.42 | $0.50 | $0.47 | $0.46 | $0.44 | $0.42 | $0.41 | $0.45 | $0.32 | $0.41 | $0.10 | $-0.23 | $0.10 | $0.49 | $0.43 |
Low Forecast | $0.36 | $0.32 | $0.33 | $0.31 | $0.32 | $0.27 | $0.26 | $0.21 | $0.19 | $0.09 | $0.27 | $0.32 | $0.31 | $0.42 | $0.40 | $0.40 | $0.48 | $0.47 | $0.46 | $0.44 | $0.42 | $0.41 | $0.45 | $0.32 | $0.41 | $0.10 | $-0.23 | $0.10 | $0.49 | $0.43 |
Surprise % | - | - | - | - | - | - | - | - | - | - | - | - | -3.72% | - | 0.71% | 0.65% | 0.92% | 0.61% | 0.63% | 1.05% | 0.61% | 1.43% | 1.23% | 1.42% | 1.64% | 2.22% | 2.58% | -1.13% | 0.71% | 1.12% |
Forecast
Envista Peer Comparison by Price Target
Ticker | Company | Last Closing Price | Avg Price Target | Upside/Downside | Avg Rating |
---|---|---|---|---|---|
ANGO | AngioDynamics | $8.69 | $13.00 | 49.60% | Buy |
AKYA | Akoya Biosciences | $2.41 | $3.50 | 45.23% | Buy |
TFX | Teleflex | $176.88 | $254.50 | 43.88% | Buy |
HAE | Haemonetics | $77.41 | $107.00 | 38.23% | Buy |
ATRC | AtriCure | $30.50 | $39.67 | 30.07% | Buy |
ATR | AptarGroup | $159.35 | $200.00 | 25.51% | Buy |
COO | Cooper Companies | $92.81 | $115.00 | 23.91% | Buy |
ICUI | ICU Medical | $156.89 | $190.50 | 21.42% | Buy |
ALC | Alcon | $86.08 | $104.00 | 20.82% | Buy |
WST | West Pharmaceutical Services | $331.42 | $393.00 | 18.58% | Buy |
MMSI | Merit Medical Systems | $98.08 | $108.83 | 10.96% | Buy |
NVST | Envista | $18.95 | $20.29 | 7.07% | Hold |
HOLX | Hologic | $72.68 | $74.20 | 2.09% | Buy |
RMD | ResMed | $231.79 | $233.50 | 0.74% | Hold |